🕒 Friday 15 August 2025 Fri, 15 Aug 2025

Laramide Resources has made significant progress in advancing its uranium projects across the US, Australia, and Kazakhstan, highlighted by key permitting milestones under the US FAST-41 framework and a successful $12 million private placement to fund development.

Laramide Resources Ltd. reported a reduced net loss of CAD 1.05 million for H1 2025, converting USD 3.5 million of debt into equity and securing a $12 million private placement to bolster its uranium exploration projects.

Baby Bunting Group Limited reported a remarkable 462% increase in statutory net profit after tax for FY2025, driven by strong sales growth and strategic store refurbishments. The company also advanced its sustainability initiatives and expanded its digital and retail media businesses.

Asian Battery Metals PLC has secured an exclusive option to acquire the Maikhan Uul copper-gold project near its flagship Oval discovery in Mongolia, alongside a new exploration tenement, enhancing its critical minerals portfolio.

Cochlear Limited has extended its on-market share buy-back program, allowing the company to repurchase up to AUD 75 million of its fully paid ordinary shares until August 2026.

Meridian Energy's July report reveals a notable decline in hydro storage levels alongside a surge in retail electricity sales, highlighting a complex energy landscape in New Zealand.

Cochlear Limited reported a solid FY25 with 4% revenue growth and a 1% rise in underlying profit, underpinned by new product launches and expanding evidence linking implants to reduced dementia risk. The company’s FY26 outlook signals further gains as it advances market leadership and innovation.

Cochlear Limited reported a 4% revenue rise in FY25, driven by strong implant sales and launched the world’s first smart cochlear implant system. The company forecasts up to 17% profit growth in FY26, underpinned by innovation and expanding markets.

Cochlear Limited has announced a fully franked ordinary dividend of AUD 2.15 per share for the six months ending June 2025, payable in October with multi-currency options for shareholders.

Cochlear Limited has reported steady financial growth with a 4% rise in sales revenue and a 9% increase in underlying net profit for the fiscal year ending June 2025, maintaining its dividend payout.

HealthCo Healthcare & Wellness REIT reports FY25 results marked by suspended distributions amid Healthscope receivership, while maintaining strong portfolio fundamentals and active tenant resolution efforts.

HealthCo Healthcare & Wellness REIT posted solid FY25 financials amid ongoing tenant transition challenges with Healthscope. The REIT is proactively securing alternative tenants while maintaining a robust balance sheet.

HealthCo Healthcare and Wellness REIT reported a substantial $89.3 million loss for FY25, driven by tenant payment issues and portfolio downsizing, leading to suspended distributions and a debt facility extension.